A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 11, 2011, Pages 2396-2403

  Feng, Junjie ^a   Sun, Jielin ^a   Kim, Seong Tae ^a   Lu, Yizhen ^b   Wang, Zhong ^a   Zhang, Zheng ^a   Gronberg, Henrik ^c   Isaacs, William B ^d   Zheng, S Lilly ^a   Xu, Jianfeng ^a,b,e  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c KAROLINSKA INSTITUTE   (Sweden)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BINDING PROTEIN;

ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 12Q; CHROMOSOME 13; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE LOCUS; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; SINGLE NUCLEOTIDE POLYMORPHISM;

BINDING SITES; CHROMOSOMES, HUMAN, PAIR 12; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; GENOTYPE; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 81155154345     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0523     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85. (Pubitemid 30451850)
3. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, et al.Acommon variant associated with prostate cancer in European and African populations. Nat Genet 2006;38:652-8. (Pubitemid 43927306)
4. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007;39:631-7. (Pubitemid 46676102)
5. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007;39:645-9. (Pubitemid 46676108)
6. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007;39:977-83. (Pubitemid 47185170)
7. Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, et al. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst 2007;99:1836-44. (Pubitemid 351767196)
8. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008;40:310-5. (Pubitemid 351311773)
9. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, GudbjartssonD, et al.Common sequence variantson2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008;40:281-3. (Pubitemid 351311771)
10. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008;40:316-21. (Pubitemid 351311772)
11. Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, Hayes RB, et al. Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet 2009;41:1055-7.
12. Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, Agnarsson BA, et al. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 2009;41:1122-6.
13. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, et al. Identification of sevennew prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009;41:1116-21.
14. Sun J, Zheng SL, Wiklund F, Isaacs SD, Purcell LD, Gao Z, et al. Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet 2008;40:1153-5.
15. Hsu FC, Sun J, Wiklund F, Isaacs SD, Wiley KE, Purcell LD, et al. A novel prostate cancer susceptibility locus at 19q13. Cancer Res 2009;69:2720-3.
16. Sun J, Zheng SL, Wiklund F, Isaacs SD, Li G, Wiley KE, et al. Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res 2009;69:10-5.
17. Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 2009;138:245-56.
18. Lu Y, Sun J, Kader AK, Kim ST, Kim JW, Liu W, et al. Association of prostate cancer risk withSNPsin regions containing androgen receptor binding sites captured by ChIP-on-chip analyses. Prostate (in press).
19. Lu Y, Zhang Z, Yu H, Zheng SL, Isaacs WB, Xu J, et al. Functional annotation of risk loci identified through genome-wide association studies for prostate cancer. Prostate 2011;71:955-63.
20. Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev 2004;25:276-308. (Pubitemid 38501396)
21. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 1972;22:232-40.
22. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-24. (Pubitemid 36859473)
23. Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med;362:1192-202.
24. Knudsen KE, Scher HI. Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer. Clin Cancer Res 2009;15:4792-8.
25. Yuan X, Balk SP. Mechanisms mediating androgen receptor reactivation after castration. Urol Oncol 2009;27:36-41.
26. Available from: http://www.illumina.com/science/icontroldb.ilmn.
27. Sun J, Kader AK, Hsu FC, Kim ST, Zhu Y, Turner AR, et al. Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer. Prostate.
28. Available from: http://www.hapmap.org.
29. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genomewide association studies. Nat Genet 2006;38:904-9. (Pubitemid 44141658)
30. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007;39:906-13. (Pubitemid 47014502)
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75. (Pubitemid 47330214)
32. Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol 2008;129:705-33.
33. Baribault H, Price J, Miyai K, Oshima RG. Mid-gestational lethality in mice lacking keratin 8. Genes Dev 1993;7:1191-202. (Pubitemid 23207410)
34. Casanova ML, Bravo A, Ramirez A, Morreale de Escobar G, Were F, Merlino G, et al. Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8. J Clin Invest 1999;103:1587-95.
35. Chu YW, Seftor EA, Romer LH, Hendrix MJ. Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am J Pathol 1996;148:63-9. (Pubitemid 26019644)
36. Hendrix MJ, Seftor EA, Seftor RE, Trevor KT. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol 1997;150:483-95. (Pubitemid 27073779)
37. Mizuuchi E, Semba S, Kodama Y, Yokozaki H. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression. Int J Cancer 2009;124:1802-10.
38. Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G, Jakobsdottir M, et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 2009;41:909-14.
39. He HH, Meyer CA, Shin H, Bailey ST, Wei G,WangQ, et al. Nucleosome dynamics define transcriptional enhancers. Nat Genet;42:343-7.
40. Wang XH, Hsieh JT. [Localization and regulation of cytokeratin 8 mRNA expression in rat prostate epithelia]. Shi Yan Sheng Wu Xue Bao 1994;27:447-55.
41. Kruglyak L. The road to genome-wide association studies. Nat Rev Genet 2008;9:314-8. (Pubitemid 351399831)